POST Online Media Lite Edition


FTC approves final order imposing conditions on Stryker Corp.’s acquisition of Wright Medical

Christian Fernsby |
The Federal Trade Commission has approved a final order settling charges that medical device company Stryker Corp.’s proposed $4 billion acquisition of competitor Wright Medical Group N.V. would violate federal antitrust law.

Article continues below


According to the complaint, which was first announced in November 2020, the proposed acquisition would likely result in substantial competitive harm to consumers in the U.S. markets for total ankle replacements and finger joint implants.

The final order requires Stryker and Wright to divest all assets associated with Stryker’s total ankle replacements and finger joint implants to DJO Global, allowing it to become an independent, viable, and effective competitor in these markets. The Commission vote to approve the final order was 5-0.

What to read next

Tronox to vigorously fight FTC lawsuit against Cristal acquisition
Wright Medical Group and Tornier to merge in $3.3 billion company
Medical device suppliers’ merger raises CMA concerns